KCNN4 promotes the progression of lung adenocarcinoma by activating the AKT and ERK signaling pathways

被引:13
|
作者
Xu, Ping [1 ,2 ,3 ]
Mo, Xiao [1 ,2 ,3 ]
Xia, Ruixue [7 ]
Jiang, Long [8 ]
Zhang, Chengfei [1 ,2 ,3 ]
Xu, Haojun [1 ,2 ,3 ]
Sun, Qi [1 ,2 ,3 ,9 ]
Zhou, Guoren [4 ,5 ,6 ]
Zhang, Yijie [7 ]
Wang, Yongsheng [9 ]
Xia, Hongping [1 ,2 ,3 ,4 ,5 ,6 ,7 ]
机构
[1] Nanjing Med Univ, Sch Basic Med Sci, Dept Pathol, Nanjing 211166, Jiangsu, Peoples R China
[2] Nanjing Med Univ, Sir Run Run Hosp, Nanjing 211166, Jiangsu, Peoples R China
[3] Nanjing Med Univ, Key Lab Antibody Tech, Natl Hlth Commiss, Nanjing 211166, Jiangsu, Peoples R China
[4] Nanjing Med Univ, Jiangsu Canc Hosp, Nanjing 210009, Jiangsu, Peoples R China
[5] Nanjing Med Univ, Affiliated Canc Hosp, Nanjing 210009, Jiangsu, Peoples R China
[6] Nanjing Med Univ, Jiangsu Inst Canc Res, Nanjing 210009, Jiangsu, Peoples R China
[7] Henan Univ, Huaihe Hosp, Dept Resp & Crit Care Med, Kaifeng 475000, Henan, Peoples R China
[8] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Shanghai Lung Canc Ctr, Shanghai, Peoples R China
[9] Nanjing Univ, Med Sch, Nanjing Drum Tower Hosp, Nanjing 210008, Jiangsu, Peoples R China
关键词
KCNN4; lung adenocarcinoma; AKT; ERK; proliferation; CANCER CELLS; MACROPHAGES; INHIBITION; EXPRESSION; INCREASES; PROGNOSIS; APOPTOSIS; KCA3.1;
D O I
10.3233/CBM-201045
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: Potassium channels, encoded by more than seventy genes, are cell excitability transmembrane proteins and become evident to play essential roles in tumor biology. OBJECTIVE: The deregulation of potassium channel genes has been related to cancer development and patient prognosis. The objective of this study is to understand the role of potassium channels in lung cancer. METHODS: We examined all potassium channel genes and identified that KCNN4 is the most significantly overexpressed one in lung adenocarcinoma. The role and mechanism of KCNN4 in lung adenocarcinoma were further investigated by in vitro cell and molecular assay and in vivo mouse xenograft models. RESULTS: We revealed that the silencing of KCNN4 significantly inhibits cell proliferation, migration, invasion, and tumorigenicity of lung adenocarcinoma. Further studies showed that knockdown of KCNN4 promotes cell apoptosis, induces cell cycle arrested in the S phase, and is associated with the epithelial to mesenchymal transition (EMT) process. Most importantly, we demonstrated that KCNN4 regulates the progression of lung adenocarcinoma through P13K/AKT and MEK/ERK signaling pathways. The use of inhibitors that targeted AKT and ERK also significantly inhibit the proliferation and metastasis of lung adenocarcinoma cells. CONCLUSIONS: This study investigated the function and mechanism of KCNN4 in lung adenocarcinoma. On this basis, this means that KCNN4 can be used as a tumor marker for lung adenocarcinoma and is expected to become an important target for a potential drug.
引用
收藏
页码:187 / 201
页数:15
相关论文
共 50 条
  • [41] Hypoxia Activates Notch4 via ERK/JNK/P38 MAPK Signaling Pathways to Promote Lung Adenocarcinoma Progression and Metastasis
    Li, Xiaochen
    Cao, Xiaopei
    Zhao, Hanqiu
    Guo, Mingzhou
    Fang, Xiaoyu
    Li, Ke
    Qin, Lu
    He, Yuanzhou
    Liu, Xiansheng
    [J]. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [42] TRIB3 promotes lung cancer progression by activating β-catenin signaling
    Zhang, Xiaochuan
    Zhong, Ning
    Li, Xing
    Chen, Min-Bin
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2019, 863
  • [43] EDAG-1 promotes the proliferation of human T-acute lymphoblastic leukemia cells by activating MAPK/Erk and Akt signaling pathways
    He, Daiying
    Luo, Zhibin
    Li, Bibo
    He, Mei
    Xia, Kanji
    Li, Jing
    Wang, Chen
    Wu, Yuni
    Xu, Yizhi
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (04): : 4173 - 4181
  • [44] Fibroblast activation protein in osteosarcoma cells promotes angiogenesis via AKT and ERK signaling pathways
    Zeng, Chao
    Wen, Ming
    Liu, Xiaomei
    [J]. ONCOLOGY LETTERS, 2018, 15 (04) : 6029 - 6035
  • [45] NSD2 Promotes Renal Cancer Progression Through Stimulating Akt/Erk Signaling
    Han, Xu
    Piao, Lianhua
    Xu, Xiaoshuang
    Luo, Fengbao
    Liu, Zhiwei
    He, Xiaozhou
    [J]. CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 375 - 383
  • [46] HSCs-derived COMP drives hepatocellular carcinoma progression by activating MEK/ERK and PI3K/AKT signaling pathways
    Qing Li
    Cong Wang
    Yufeng Wang
    Liankang Sun
    Zhikui Liu
    Liang Wang
    Tao Song
    Yingmin Yao
    Qingguang Liu
    Kangsheng Tu
    [J]. Journal of Experimental & Clinical Cancer Research, 37
  • [47] HSCs-derived COMP drives hepatocellular carcinoma progression by activating MEK/ERK and PI3K/AKT signaling pathways
    Li, Qing
    Wang, Cong
    Wang, Yufeng
    Sun, Liankang
    Liu, Zhikui
    Wang, Liang
    Song, Tao
    Yao, Yingmin
    Liu, Qingguang
    Tu, Kangsheng
    [J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2018, 37
  • [48] SEM1 promotes tumor progression of glioblastoma via activating the akt signaling pathway
    Li, Chuntao
    Chen, Bo
    Zhang, Junxia
    Yang, Jingxuan
    Guo, Muzi
    Ren, Yu
    Zhou, Zhijun
    Fung, Kar-Ming
    Li, Min
    Zhang, Liyang
    Liu, Zhixiong
    [J]. CANCER LETTERS, 2023, 577
  • [49] ENKUR acts as a tumor suppressor in lung adenocarcinoma cells through PI3K/Akt and MAPK/ERK signaling pathways
    Ma, Qing
    Lu, Yin
    Lin, Jie
    Gu, Ye
    [J]. JOURNAL OF CANCER, 2019, 10 (17): : 3975 - 3984
  • [50] NCAPG promotes the progression of lung adenocarcinoma via the TGF-β signaling pathway
    Yun Wu
    Ying Lin
    Junfan Pan
    Xunwei Tu
    Yiquan Xu
    Hongru Li
    Yusheng Chen
    [J]. Cancer Cell International, 21